Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Jan;59(1):14–21. doi: 10.1172/JCI108611

Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.

J W Shaw, S B Oldham, L Rosoff, J E Bethune, M P Fichman
PMCID: PMC333327  PMID: 187621

Abstract

Urinary cyclic AMP (UcAMP) appropriate for the serum calcium concentration was determined in normal subjects during the base-line state and during alteration in their serum calcium concentrations by saline and calcium infusions. This was compared to the UcAMP in 76 patients with hypercalcemia and 5 patients with hypocalcemia. In 54 of 56 patients with primary hyperparathyroidism, the UcAMP was inappropriately high for their serum calcium concentration, the 2 exceptions having renal failure. In four patients with vitamin D intoxication, sarcoidosis, milkalkali syndrome, and thiazide-induced hypercalcemia and in five patients with hypocalcemia due to hypoparathyroidism, the UcAMP was appropriately low for their serum calcium concentration. In 16 patients with nonparathyroid neoplasms, 10 had UcAMP levels that were inappropriately high suggesting ectopic parathyroid hormone (PTH)-mediated hypercalcemia and 6 had UcAMP levels that were appropriately low suggesting that their hypercalcemia was due to osteolytic factors other than PTH. Correlations between UcAMP, serum calcium concentration, and carboxyl-terminal immunoreactive PTH suggest that random UcAMP is a sensitive accurate reflection of circulating biologically active PTH. If there is adequate renal function (serum creatinine concentration less than 2.0 mg/dl), a random UcAMP expressed as mumol/g creatinine and analyzed as a function of the serum calcium concentration completely separates patients with PTH and non-PTH-mediated hypercalcemia.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnaud C. D., Goldsmith R. S., Bordier P. J., Sizemore G. W. Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man. Am J Med. 1974 Jun;56(6):785–793. doi: 10.1016/0002-9343(74)90806-7. [DOI] [PubMed] [Google Scholar]
  2. Arnaud C. D., Tsao H. S., Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest. 1971 Jan;50(1):21–34. doi: 10.1172/JCI106476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benson R. C., Jr, Riggs B. L., Pickard B. M., Arnaud C. D. Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med. 1974 Jun;56(6):821–826. doi: 10.1016/0002-9343(74)90810-9. [DOI] [PubMed] [Google Scholar]
  4. Dohan P. H., Yamashita K., Larsen P. R., Davis B., Deftos L., Field J. B. Evaluation of urinary cyclic 3'5'-adenosine monophosphate excretion in the differential diagnosis of hypercalcemia. J Clin Endocrinol Metab. 1972 Dec;35(6):775–784. doi: 10.1210/jcem-35-6-775. [DOI] [PubMed] [Google Scholar]
  5. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kaminsky N. I., Broadus A. E., Hardman J. G., Jones D. J., Jr, Ball J. H., Sutherland E. W., Liddle G. W. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest. 1970 Dec;49(12):2387–2395. doi: 10.1172/JCI106458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaplan L., Katz A. D., Ben-Isaac C., Massry S. G. Malignant neoplasms and parathyroid adenoma. Cancer. 1971 Aug;28(2):401–407. doi: 10.1002/1097-0142(197108)28:2<401::aid-cncr2820280221>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  8. Murad F., Pak C. Y. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. N Engl J Med. 1972 Jun 29;286(26):1382–1387. doi: 10.1056/NEJM197206292862604. [DOI] [PubMed] [Google Scholar]
  9. Neelon F. A., Birch B. M., Drezner M., Lebovitz H. E. Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism. Lancet. 1973 Mar 24;1(7804):631–633. doi: 10.1016/s0140-6736(73)92199-5. [DOI] [PubMed] [Google Scholar]
  10. Pak C. Y., Oata M., Lawrence E. C., Snyder W. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest. 1974 Aug;54(2):387–400. doi: 10.1172/JCI107774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Potts J. T., Jr, Murray T. M., Peacock M., Niall H. D., Tregear G. W., Keutmann H. T., Powell D., Deftos L. J. Parathyroid hormone: sequence, synthesis, immunoassay studies. Am J Med. 1971 May;50(5):639–649. doi: 10.1016/0002-9343(71)90119-7. [DOI] [PubMed] [Google Scholar]
  12. Powell D., Singer F. R., Murray T. M., Minkin C., Potts J. T., Jr Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med. 1973 Jul 26;289(4):176–181. doi: 10.1056/NEJM197307262890403. [DOI] [PubMed] [Google Scholar]
  13. Sagel J., Colwell J. A., Loadholt C. B., Lizarralde G. Circadian rhythm in the urinary excretion of cyclic 3',5'-adenosine monophosphate in man. J Clin Endocrinol Metab. 1973 Oct;37(4):570–573. doi: 10.1210/jcem-37-4-570. [DOI] [PubMed] [Google Scholar]
  14. Segre G. V., Habener J. F., Powell D., Tregear G. W., Potts J. T. Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. J Clin Invest. 1972 Dec;51(12):3163–3172. doi: 10.1172/JCI107143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shaw J. W., Oldham S. B., Bethune J. E., Fichman M. P. Parathyroid hormone (PTH)-mediated rise in urinary cyclic AMP(UcAMP) during acute extracellular fluid (ECF) expansion natriuresis in man. J Clin Endocrinol Metab. 1974 Aug;39(2):311–315. doi: 10.1210/jcem-39-2-311. [DOI] [PubMed] [Google Scholar]
  16. Taylor A. L., Davis B. B., Pawlson L. G., Josimovich J. B., Mintz D. H. Factors influencing the urinary excretion of 3',5'-adenosine monophosphate in humans. J Clin Endocrinol Metab. 1970 Mar;30(3):316–324. doi: 10.1210/jcem-30-3-316. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES